Literature DB >> 19767566

Protumor vs antitumor functions of IL-17.

Gopal Murugaiyan1, Bhaskar Saha.   

Abstract

Inflammation appears to be a necessity for both metastasis and elimination of tumor cells. IL-17, a proinflammatory cytokine produced by Th17 cells, contributes to both the processes by playing a dual role in the antitumor immunity. On one hand, IL-17 promotes an antitumor cytotoxic T cell response leading to tumor regression. On the other hand, by facilitating angiogenesis and egress of tumor cells from the primary focus, IL-17 promotes tumor growth. Thus, the therapeutic application that uses IL-17 needs to be refined by minimizing its protumor functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767566     DOI: 10.4049/jimmunol.0901017

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  151 in total

1.  The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas.

Authors:  Lubin Qiu; Dongsheng He; Xiang Fan; Zhi Li; Chuangxin Liao; Yonghong Zhu; Haijun Wang
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

Review 2.  Dendritic cell vaccination against ovarian cancer--tipping the Treg/TH17 balance to therapeutic advantage?

Authors:  Martin J Cannon; Hannah Goyne; Pamela J B Stone; Maurizio Chiriva-Internati
Journal:  Expert Opin Biol Ther       Date:  2011-01-28       Impact factor: 4.388

Review 3.  Dietary agents in cancer prevention: an immunological perspective.

Authors:  Ya Ying Zheng; Bharathi Viswanathan; Pravin Kesarwani; Shikhar Mehrotra
Journal:  Photochem Photobiol       Date:  2012-03-30       Impact factor: 3.421

4.  Sodium channel γENaC mediates IL-17 synergized high salt induced inflammatory stress in breast cancer cells.

Authors:  Suneetha Amara; Michael T Ivy; Elbert L Myles; Venkataswarup Tiriveedhi
Journal:  Cell Immunol       Date:  2015-12-19       Impact factor: 4.868

5.  Pituitary adenylate cyclase-activating peptide and vasoactive intestinal polypeptide bias Langerhans cell Ag presentation toward Th17 cells.

Authors:  Wanhong Ding; Michela Manni; Lori L Stohl; Xi K Zhou; John A Wagner; Richard D Granstein
Journal:  Eur J Immunol       Date:  2012-04       Impact factor: 5.532

Review 6.  The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

Authors:  N D Turner; L E Ritchie; R S Bresalier; R S Chapkin
Journal:  Curr Gastroenterol Rep       Date:  2013-09

7.  Interleukin-17 (IL-17) and IL-1 activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1.

Authors:  Sonam Dhamija; Reinhard Winzen; Anneke Doerrie; Gesine Behrens; Nancy Kuehne; Celina Schauerte; Elena Neumann; Oliver Dittrich-Breiholz; Michael Kracht; Helmut Holtmann
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

8.  Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression.

Authors:  M Jaganjac; M Poljak-Blazi; R J Schaur; K Zarkovic; S Borovic; A Cipak; M Cindric; K Uchida; G Waeg; N Zarkovic
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

9.  TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade.

Authors:  V Cervera-Carrascon; M Siurala; J M Santos; R Havunen; S Tähtinen; P Karell; S Sorsa; A Kanerva; A Hemminki
Journal:  Oncoimmunology       Date:  2018-04-09       Impact factor: 8.110

10.  Loss of Interleukin-17RA Expression is Associated with Tumour Progression in Colorectal Carcinoma.

Authors:  Boon Yean Chai; Wai Kien Yip; Noraini Dusa; Norhafizah Mohtarrudin; Heng Fong Seow
Journal:  Pathol Oncol Res       Date:  2020-05-27       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.